Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-013811
Filing Date
2023-04-28
Accepted
2023-04-28 08:34:21
Documents
2
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A fy2022proxystatement.htm DEF 14A 508964
2 image_0a.jpg GRAPHIC 6694
  Complete submission text file 0001628280-23-013811.txt   519282
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41536 | Film No.: 23860549
SIC: 2836 Biological Products, (No Diagnostic Substances)